|
|
|
12:30–1:30
pm |
Ahmed, Khatija,
Nazira Cassim, Malebo Rathlagana,
Barbara Friedland,
Taja Ferguson, Hillary Bracken, and
C. Johannes van Dam.
"An evaluation of the strategies for care and support of women who
test positive for HIV during screening for the Phase 3 trial of CarraguardTM in Soshanguve, South Africa"
(poster) (abstract)
|
|
|
Bollen, Liesbeth, Kelly Blanchard, Peter Kilmarx, Supaporn
Chaikummao, Cathy Connolly, Punneporn Wasinrapee, Jullapong
Achalapong, Janet McNicholl, and Jordan Tappero. "No increase in
cervicovaginal pro-inflammatory cytokines after Carraguard®
use" (abstract) |
|
|
Cassim, Nazira, Khatija
Ahmed, Gita
Ramjee, Thesla Palanee, Tselane Thebe,
Lydia Altini, Smruti
Patel, Pekka Lähteenmäki,
Stephanie Skoler,
and Frank J. Kizis. "The prevalence of abnormal Pap smear
lesions in HIV-positive and -negative women screened for the Phase 3
trial of Carraguard" (abstract) |
|
|
Champion, Rukshana, Stephanie Skoler, and
Lydia Altini.
"Managing the complexities of the Phase 3 microbicide budget: Exceeding expectations" (abstract) |
|
|
de Kock, Alana, Neetha S. Morar,
Barbara Friedland,
Stephanie Skoler,
Frank J. Kizis, Vuyelwa Mehlomakulu, and Mabitso Marumo. "Counseling
challenges and concerns in a Phase 3 microbicide trial" (abstract)
|
|
|
Fernández-Romero, Jose A., Stuart Turville, Todd Miller, Ines
Frank, Melissa
Robbiani (Pope), Kanani E. Titchen,
Robin A. Maguire,
and David M.
Phillips. "Carrageenan and MIV-150 block uptake and
transmission of HIV-1 by primary cervico ectoepithelial cells"
(poster) (abstract)
|
|
Fernández-Romero, Jose A., Mitchell Thorn, Kanani E. Titchen,
Kristin M. Sudol, Jifan Li,
Robin A. Maguire,
Robert W. Buckheit, Jr., Tracy L. Hartman, and
David M. Phillips.
"Carrageenan/MIV-150 (PC-815): A combination microbicide"
(poster) (abstract)
|
|
|
Giaiminietti, Lara, Kalendri Naidoo, Natasha A. Chetty, Thiroshni Govender, Thesla Palanee,
Neetha S. Morar, and
Gita Ramjee. "Participant retention strategies in an ongoing
Phase 3 Carraguard® microbicide trial in Durban, South Africa"
(abstract)
|
|
|
Govender,
Sumentheran N.,
Pekka Lähteenmäki;
David Ingram,
Stephanie Skoler, and
Robin A. Maguire. "Bar coding: A new innovative way for drug
dispensing and site management" (abstract)
|
|
|
Hart, Clyde, Catherine McLean, Tammy Evans-Strickfaden,
Heidi Jones, John
Karon, Janet McNicholl, and Janneke van de Wijgert. "Detection of
cervicovaginal infectious and replicating HIV-1 in the evaluation of
Carraguard™ microbicide use in HIV-infected women: A
Phase 1 randomized, controlled, crossover study in Chiang Rai,
Thailand" (abstract)
|
|
|
Naidoo,
Kalendri, E. Dorsamy, B. Naidoo, C. Munsami, K. Gumede,
Roshini Govinden, and Gita
Ramjee. "Preventing co-enrollment in multiple clinical
trials in Durban, South Africa" (abstract)
|
|
|
Khunou, Lerato, Khatija
Ahmed, Nazira Cassim, M. Moloi, Frank J. Kizis, and
Stephen Eghan. "The prevalence of STIs in HIV-positive versus
HIV-negative women in the Phase 3 Carraguard clinical trials, at
Soshanguve north of Pretoria" (abstract)
|
|
|
Kunene, Tusani H., Thesla Palanee, Tselane Thebe, S. Mbonambi, T. Mbeje, N. Langa,
N. Mqgundaniso, N. Makhanya, Neetha S. Morar, and
Gita Ramjee.
"Disclosure of HIV status among women screened for participation in
the Carraguard® Phase 3 trial in Durban, South Africa" (abstract)
|
|
|
Langa, Z., Tselane Thebe, Thesla Palanee, Neetha S. Morar, and
Gita Ramjee. "Syndromic
management of STIs: Comparison between clinical and laboratory
findings" (abstract)
|
|
|
Langa, Z.G., Tselane Thebe, N. Cele, L. Mbobo, Z. Shange, N. Mnyandu,
Thesla Palanee, Neetha S. Morar, and
Gita Ramjee.
"Problems encountered in treating women with sexually transmitted
infections in the Carraguard Phase 3 trial" (abstract)
|
|
|
Maguire, Robin A.,
Andrea Wallace, Jose A. Fernández-Romero, Jifan Li, Mitchell
Thorn, Kristin M. Sudol, Kanani E. Titchen, Robert
W.
Buckheit Jr., Tracy L. Hartman, and
David M. Phillips.
"Zinc-carrageenan (PC-710): A novel microbicide" (poster) (abstract)
|
|
|
McLean, Catherine, Heidi Jones, Janet McNicholl, Janneke van de Wijgert,
Tepnaruemit Medtanavyn, Wat Uthaiworavit, Sara Whitehead, John Karon,
and Lauri Markowitz. "Effect of Carraguard™ gel use on
cell-free HIV-1 RNA cervicovaginal shedding in HIV-infected women: A
Phase 1 randomized, controlled crossover study in Chiang Rai,
Thailand" (abstract)
|
|
|
Mthembu, Nobuhle, S. Mthethwa, D. Dlamini, G. Hlongwane, Sicelo
Gumede, Tusani H. Kunene, Thesla Palanee, Neetha S. Morar, and
Gita Ramjee.
"Challenges in recruiting young women between the ages of 16 and
21 years in the Phase 3 Carraguard clinical trial in Durban, South
Africa" (abstract)
|
|
|
Naidoo, Kalendri, Thesla Palanee, and
Gita Ramjee.
"Development of tools to improve syphilis treatment compliance among
women in the Carraguard Phase 3 trial" (abstract)
|
|
|
Ngcozela, Veronica, Alana de Kock, and
Lydia Altini.
"Challenges of recruitment strategies, including community
involvement, in the Phase 3 Carraguard trial in Gugulethu, Cape
Town" (abstract)
|
|
|
Palanee, Thesla, Neetha S. Morar, Frank J. Kizis,
Lydia Altini, Smruti
Patel, Khatija Ahmed,
Nazira Cassim, and
Gita Ramjee. "HIV and STI prevalence among women screened at
three sites within South Africa for inclusion in the Phase 3
Carraguard® microbicide clinical trial" (abstract)
|
|
|
Pillay, L., Thesla Palanee, Hlengiwe Vilakazi, and
Gita Ramjee.
"Co-infections of Trichomonas vaginalis, Neisseria
gonorrhoeae and Chlamydia trachomatis in HIV-positive
women screened out in Carraguard Phase 3 clinical trial site,
Durban, South Africa" (abstract)
|
|
|
Sudol, Kristin M. and
David M. Phillips.
"Relative safety of OTC sexual lubricants for rectal intercourse"
(poster)(abstract)
|
|
|
Titchen, Kanani E., Jifan Li, Livia Wan, Laura Guichard,
Robin A. Maguire,
and
David M. Phillips.
"Retention time of Carraguard® in the human vagina"
(poster)
(abstract)
|
|
